Capital Increase / Dilution2026-07-09

CB Maturity Extended, Conversion Period Adjusted

BIO

바이오프로테크

199290

-0.15

Signal Score

51CNeutral
Score51 / 100

Historical Avg Return (5d)

+0.22%

Data Coverage

100%n=2507

Risk-adjusted indicator based on 2507 historical DART filings. For informational purposes only — not investment advice.

Financial Impact

NEUTRAL

Key Numbers

  • • 11th CB Maturity Date (Before): July 9, 2026
  • • 11th CB Maturity Date (After): July 9, 2028
  • • 11th CB Conversion Request Period End (Before): June 9, 2026
  • • 11th CB Conversion Request Period End (After): June 9, 2028
  • • Total Unredeemed CBs (Principal): 3.15B KRW
  • • Total Convertible Shares: 1,550,396 Shares
  • • Dilution Rate (vs. Existing Shares): 7.02%
  • • 11th CB Conversion Price: 500 KRW/Share

AI Analysis Summary

BIO PROTECH INC. has amended its Material Fact Report regarding the issuance of convertible bonds. The maturity date for the 11th series of convertible bonds has been extended from July 9, 2026, to July 9, 2028, with a corresponding extension of the conversion request period. The total principal amount of unredeemed convertible bonds remains at 3.15 billion KRW, representing 1,550,396 potential shares, which could lead to a maximum dilution of 7.02% against the current 22,076,554 outstanding shares. The conversion price for the 11th CB is 500 KRW per share, determined by an external valuation due to the company's trading suspension since March 20, 2020. The report also grants investors the right to nominate a non-executive director and a co-representative director. This amendment primarily adjusts timelines for existing CBs, maintaining the overall dilution risk.

How This Event Is Evaluated

Capital Raise Evaluation

Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.

AI is used to interpret disclosures and extract structured data.

Signal scores are generated using event-specific methodologies and quantitative models.

  • Potential dilution rate
  • Issuance or conversion price
  • Funding purpose
  • Shareholder value impact
Read our full scoring methodology →

Track Korean Market Signals — Free

Sign up free to access live disclosures, AI analysis, and event filters.

Public Beta · No credit card required

This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.

AI-processed analysis. Based on: [기재정정]주요사항보고서(전환사채권발행결정). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.